chronic
kidney
diseas
epidemiolog
identifi
risk
factor
develop
sever
dengu
dengueaffect
patient
howev
avail
data
immun
pathogenesi
end
stage
renal
diseas
esrd
patient
affect
dengu
insuffici
perform
vitro
studi
evalu
sequenti
immunolog
reaction
viral
load
dengu
viru
type
mononuclear
cell
patient
esrd
n
healthi
control
n
concentr
interleukin
il
receptor
antagonist
ra
granulocytemacrophag
colonystimul
factor
gmcsf
monocyt
chemotact
macrophag
inflammatori
vascular
endotheli
growth
factor
vegf
tumor
necrosi
factor
tnf
viral
load
cycl
threshold
ct
measur
dengu
viru
type
dengu
gener
consid
pediatr
diseas
howev
recent
decad
advanc
age
report
risk
factor
patient
sever
dengu
comorbid
associ
age
pose
substanti
risk
mortal
elderli
patient
chronic
kidney
diseas
implic
develop
sever
dengu
thein
et
al
studi
patient
dengu
report
renal
disord
increas
odd
death
adult
kuo
et
al
report
patient
chronic
kidney
diseas
higher
mortal
rate
without
chronic
kidney
diseas
studi
adult
dengu
chronic
renal
diseas
found
risk
factor
contribut
develop
acut
kidney
injuri
associ
high
morbid
mortal
affect
patient
wong
et
al
found
end
stage
renal
diseas
esrd
risk
factor
acut
respiratori
failur
dengu
affect
adult
esrd
also
import
clinic
predictor
gastrointestin
bleed
adult
patient
dengu
fact
patient
esrd
suscept
infect
bacteri
sepsi
poor
clinic
outcom
compar
gener
popul
spite
esrd
increasingli
common
diseas
lack
enough
data
immun
pathogenesi
esrd
patient
affect
dengu
thu
thorough
investig
urgent
requir
better
understand
immun
respons
dengueaffect
esrd
patient
present
studi
aim
explor
sequenti
immunolog
reaction
viral
load
vitro
investig
dengu
virusinfect
mononuclear
cell
adult
esrd
would
eventu
make
possibl
target
intervent
improv
treatment
plan
dengu
infect
ethic
statement
studi
approv
institut
review
board
kaohsiung
chang
gung
memori
hospit
medic
center
taiwan
document
written
inform
consent
particip
obtain
research
adher
principl
declar
helsinki
studi
period
particip
studi
conduct
kaohsiung
chang
gung
memori
hospit
januari
decemb
volunt
recruit
suffer
esrd
healthi
control
age
control
studi
esrd
affect
volunt
refer
individu
chronic
kidney
diseas
undergo
hemodialysi
therapi
thrice
week
ml
sampl
blood
obtain
particip
esrd
healthi
individu
avoid
influenc
dialyz
express
immun
mediat
blood
sampl
esrd
volunt
collect
start
dialysi
session
blood
sampl
particip
test
dengu
virusspecif
immunoglobulin
igm
igg
antibodi
use
dengu
blot
detect
kit
gene
lab
diagnost
singapor
determin
previou
dengu
infect
blood
sampl
anonym
complet
demograph
data
collect
prepar
mononuclear
cell
whole
blood
particip
esrd
healthi
individu
separ
plasma
blood
cell
ie
leukocyt
erythrocyt
centrifug
rpm
g
minut
erythrocyt
remov
blood
cell
dextran
sediment
remov
erythrocyt
leukocyt
separ
mononuclear
cell
neutrophil
use
densiti
gradient
centrifug
min
ficollpaqu
plu
amersham
bioscienc
corp
accord
procedur
describ
elsewher
mononuclear
cell
esrd
healthi
individu
suspend
rpmi
medium
gibco
seed
cultur
plate
densiti
cell
per
well
day
southern
taiwan
predomin
serotyp
outbreak
seri
vitro
model
mononuclear
cell
infect
design
new
guinea
c
strain
atcc
obtain
institut
prevent
medicin
nation
defens
medic
center
taipei
viru
propag
aed
albopictu
cell
eagl
minim
essenti
medium
gibco
brl
grand
island
ny
usa
day
viru
titer
determin
base
standard
plaqu
form
unit
pfu
assay
babi
hamster
cell
describ
previous
viru
titer
adjust
pfuml
rpmi
gibco
brl
medium
achiev
suffici
virusinfect
mononuclear
cell
avoid
excess
cellular
apoptosi
use
multipl
infect
moi
proven
appropri
previous
cell
cultur
plate
densiti
cell
per
well
inocul
moi
incub
hour
infect
mononuclear
cell
wash
remov
extracellular
virus
cultur
rpmi
medium
incub
supernat
cell
wwwnaturecomscientificreport
wwwnaturecomscientificreport
determin
cycl
threshold
ct
valu
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
viral
rna
extract
cultur
mononuclear
cell
esrd
healthi
individu
measur
ct
valu
realtim
rtpcr
previous
describ
forward
primer
revers
primer
taqman
probe
sequenc
detect
respect
data
statist
analys
measur
immun
mediat
express
mean
valu
standard
deviat
pgml
viral
load
determin
ct
valu
rtpcr
mannwhitney
u
test
use
analyz
differ
immun
mediat
viral
load
variou
time
point
h
h
h
h
postinfect
esrd
control
group
p
valu
consid
statist
signific
analys
perform
use
spss
chicago
il
usa
demograph
characterist
particip
cell
obtain
particip
includ
esrd
patient
men
women
median
age
year
healthi
control
men
women
median
age
year
among
esrd
affect
particip
hypertens
common
comorbid
follow
type
diabet
mellitu
none
particip
control
group
underli
medic
condit
particip
test
neg
dengu
virusspecif
immunoglobulin
igm
igg
antibodi
determin
dengu
blot
detect
kit
immun
profil
overal
esrd
affect
particip
control
figur
immun
profil
esrd
affect
particip
without
diabet
beyond
viral
factor
current
evid
shown
diabet
potenti
import
cofactor
affect
outcom
dengu
infect
elimin
impact
diabet
product
immun
mediat
esrd
patient
subgroup
analysi
perform
esrd
particip
without
diabet
n
control
group
n
fig
h
postinfect
gmcsf
detect
higher
concentr
signific
reduct
stimul
mononuclear
cell
product
esrd
without
diabet
group
control
group
h
h
h
postinfect
level
still
low
esrd
without
diabet
group
control
group
addit
significantli
lower
concentr
vegf
observ
h
postinfect
esrd
without
diabet
group
comparison
control
chronic
kidney
diseas
found
epidemiolog
identifi
risk
factor
develop
dengu
hemorrhag
fever
among
dengu
patient
howev
previous
publish
research
dengu
immun
pathogenesi
involv
gener
popul
rather
popul
specif
underli
diseas
esrd
present
studi
eleven
immun
mediat
viral
load
ct
valu
measur
mononuclear
cell
adult
esrd
healthi
particip
urem
present
complex
multidimension
inflammatori
condit
previou
studi
shown
lymphocyt
esrd
patient
dysregul
plasma
creactiv
protein
concentr
significantli
higher
esrd
patient
predialysi
control
seri
apart
high
level
gmcsf
observ
h
postinfect
impair
product
immun
mediat
observ
later
stage
postinfect
esrd
group
find
potenti
valuabl
understand
basi
immunopatholog
reaction
provid
new
insight
manag
esrd
patient
dengu
viru
infect
patient
dengu
viru
infect
may
progress
three
clinic
phase
name
febril
phase
critic
phase
recoveri
phase
report
describ
vitro
experi
dengu
viru
infect
mononuclear
cell
analysi
immun
mediat
differ
time
infect
set
mimick
infect
human
sequenti
immunolog
reaction
wwwnaturecomscientificreport
wwwnaturecomscientificreport
level
gmcsf
significantli
rais
overal
esrd
popul
well
nondiabet
esrd
particip
h
postinfect
gmcsf
play
import
role
mediat
innat
immun
respons
stimul
stem
cell
produc
granulocyt
facilit
develop
immun
system
fight
infect
gmcsf
report
increas
significantli
patient
sever
dengu
compar
mild
dengu
import
proinflammatori
cytokin
determin
activ
thelper
respons
stimul
cellmedi
immun
kuran
et
al
studi
children
show
level
highest
one
day
defervesc
patient
dengu
hemorrhag
fever
although
gmcsf
express
higher
concentr
h
postinfect
esrd
group
product
larg
number
proand
antiinflammatori
cytokin
well
chemokin
includ
markedli
decreas
result
suggest
derang
wwwnaturecomscientificreport
wwwnaturecomscientificreport
immun
reaction
proand
antiinflammatori
cytokineschemokin
esrd
patient
earli
phase
dengu
ill
hallmark
sever
dengu
transient
perturb
blood
vessel
integr
lead
increas
vascular
permeabl
result
plasma
leakag
chang
like
due
effect
biolog
mediat
consequ
complex
interact
dengu
viru
host
innat
adapt
immun
respons
exampl
increas
level
solubl
receptor
well
vegf
wwwnaturecomscientificreport
wwwnaturecomscientificreport
report
dengu
hemorrhag
fever
case
antiinflammatori
properti
counterregul
cascad
proinflammatori
cytokin
report
correl
diseas
sever
remark
result
present
studi
show
signific
impair
express
h
h
h
postinfect
vegf
level
h
h
gmcsf
level
h
h
also
report
low
esrd
group
impair
cytokineschemokin
express
also
found
esrd
without
diabet
group
well
result
somewhat
inconsist
report
overwhelm
immun
activ
associ
dengu
diseas
sever
howev
find
clearli
reflect
impair
immun
respons
vitro
studi
mononuclear
cell
esrd
patient
uremia
per
se
also
alter
immun
system
esrd
patient
complet
blood
count
perform
seri
previou
studi
howev
shown
monocyt
monocytederiv
dendrit
cell
esrd
patient
impair
endocytosi
matur
lisowska
et
al
report
esrd
patient
lower
percentag
cell
well
b
cell
peripher
blood
fact
sever
factor
influenc
immun
esrd
patient
urem
toxin
malnutrit
chronic
inflamm
therapeut
dialysi
regard
find
previou
report
indic
esrd
patient
immun
dysregul
impair
express
immun
mediat
case
dengu
viru
infect
although
role
proand
antiinflammatori
cytokineschemokin
pathogenesi
vascular
permeabl
dengueaffect
esrd
patient
uncertain
seri
impair
immun
respons
indic
reduct
activ
immun
system
dengueaffect
esrd
patient
lead
increas
risk
morbid
mortal
case
secondari
bacteri
infect
notabl
studi
sever
dengu
patient
concurr
bacteremia
esrd
adult
dengueaffect
patient
bacteremia
found
esrd
anoth
find
recogn
studi
significantli
lower
viral
load
ct
valu
h
h
postinfect
esrd
group
control
howev
signific
differ
viral
load
ct
valu
group
found
h
h
postinfect
relationship
dengu
viral
load
sever
diseas
still
controversi
murgu
et
al
report
high
level
viral
load
might
contribut
pathogenesi
dengu
hemorrhag
fever
anoth
studi
confirm
adult
dengu
case
chen
et
al
found
viral
load
significantli
differ
dengu
fever
dengu
hemorrhag
fever
patient
studi
need
determin
role
viral
load
pathogenesi
sever
dengu
esrd
patient
limit
present
studi
unclear
whether
similar
immunolog
respons
occur
secondari
dengu
infect
dengueaffect
esrd
patient
despit
limit
first
studi
provid
basi
understand
role
immun
mediat
esrd
popul
dengu
infect
conclus
result
studi
disclos
impair
immunolog
reaction
mononuclear
cell
infect
esrd
individu
impli
caution
need
exercis
immun
dysregul
esrd
popul
might
key
determin
clinic
outcom
treat
dengueaffect
esrd
patient
studi
highlight
clinic
investig
beyond
vitro
studi
need
confirm
import
find
data
gener
analyz
studi
includ
publish
articl
